Rare diseases can be treated with tailored gene therapy but India’s regulatory system must evolve

Mint has reported a new India-focused technology development: “Rare diseases can be treated with tailored gene therapy but India’s regulatory system must evolve.” The publisher's feed describes the story as follows: India should review its regulation of new therapeutic paths enabled by tech advances. Think of AI and the wonders of Crispr gene editing. Safe ways exist to test modern therapies in a country that’s well placed to make breakthroughs. Intellectual Janata Party includes this item for
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.



